CAPSTONE INVESTMENT ADVISORS, LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$252,250
+1.7%
25,0000.0%0.00%
+100.0%
Q3 2022$248,000
+1.2%
25,0000.0%0.00%0.0%
Q2 2022$245,0000.0%25,0000.0%0.00%0.0%
Q1 2022$245,000
+0.8%
25,0000.0%0.00%
Q4 2021$243,000
+0.4%
25,0000.0%0.00%
Q3 2021$242,0000.0%25,0000.0%0.00%
-100.0%
Q2 2021$242,00025,0000.00%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
TEGEAN CAPITAL MANAGEMENT, LLC 137,133$896,4480.78%
Lynwood Capital Management Inc. 51,400$504,0000.56%
KRYGER CAPITAL Ltd 402,232$3,945,0000.27%
KIM, LLC 450,000$4,415,0000.21%
BASSO CAPITAL MANAGEMENT, L.P. 170,114$1,669,0000.18%
Knott David M Jr 36,000$353,0000.15%
Vestcor Inc 400,000$3,924,0000.15%
Castle Creek Arbitrage, LLC 253,446$2,486,0000.14%
GLAZER CAPITAL, LLC 509,934$5,002,0000.12%
PERISCOPE CAPITAL INC. 354,600$3,479,0000.09%
View complete list of IBERE PHARMACEUTICALS shareholders